Clinical trials: FDG-PET
Non-Small Cell Lung Cancer
PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1
Lung cancer is the leading cause of cancer deaths worldwide. Revolution of chemo-immunotherapy (CT-IO) in first-line of metastatic non-small-cell lung cancers (NSCLC) without actionable genomic alterations (AGAs) has dramatically…
- Trial name
- PROFIL-1 (NCT06738680)
- Testing
- LAFOV system (an innovative, latest-generation system) scan
- Where
- 2 sites in France
- Volunteers
- 120 people
- Sponsor
- University Hospital, Brest
Non Small Cell Lung Cancer
AIMN Multicenter Study: 18 F-FDG PET-CT With or Without Contrast Medium in the Staging and Radiation of Lung Cancer?
Accurate staging of patients with non-small cell cancer (NSCLC) is of fundamental importance both for the correct choice of treatment plan and for prognosis.
- Trial name
- NCT06168916
- Testing
- PET/CT with contrast medium in a single session.
- Volunteers
- 14 people
- Sponsor
- IRCCS San Raffaele
Neuro-Degenerative Disease
Study of Cerebral Glucose Metabolism in Healthy Volunteers Using 18 F-FDG PET: Evaluation of the Effects of Aging, Comparative Evaluation of Neurodegenerative and Psychiatric Pathologies.
The aim of the study is to obtain information on cerebral glucose metabolism measured with the 18F-FDG PET technique in normal subjects without current or previous neurological or psychiatric pathologies in order to use the data…
- Trial name
- NCT06164938
- Testing
- Diagnostic accuracy
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- IRCCS San Raffaele
Metabolism Disorder
Cold Induced Futile Cycles In White Adipose Tissue
Investigation of futile cycles in white adipose tissue under cold conditions for thermogenesis using two substitutes for glucose metabolism (18F-FDG and 13C-Glucose).
- Trial name
- Metabol (NCT04614116)
- Testing
- External cooling, FDG PET/CT, 13C-Glucose injection
- Where
- Switzerland
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Kantonsspital Baden
Lung Cancer, Head and Neck Cancer
A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation
Approximately 60 patients will be enrolled with highly suspected lung cancer, or head and neck cancer. The patients must also be starting radiotherapy or a chemoradiotherapy regimen (except with 5-fluorouracil).
- Trial name
- FLT101 (NCT00847509)
- Testing
- [F-18]FLT
- Where
- 2 sites in United States
- Volunteers
- 49 people
- Sponsor
- Siemens Molecular Imaging
Carcinoma, Non-small Cell Lung Cancer
Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)
This study will use imaging to look at tumor response to combination chemotherapy of gemcitabine (Gem) and cisplatin (Cis) or gemcitabine and carboplatin (Carbo) in non small cell lung cancer (NSCLC).
- Trial name
- NCT00599755
- Testing
- Comparator: CT or MRI and FDG-PET, Gemcitabine and Cisplatin or Gemcitabine and Carboplatin
- Volunteers
- 68 people
- Sponsor
- Merck Sharp & Dohme LLC